Use our new account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
Scholar

Eugene C. Tarne

Senior Analyst

Eugene C. Tarne is a senior analyst with the Charlotte Lozier Institute. He is also the president of Tarne Communications Inc., a communications and issue advocacy company he founded in 1999. For more than 25 years, beginning in 1989, Mr. Tarne served as a communications and media relations consultant to the United States Conference of Catholic Bishops Secretariat for Pro-Life Activities. In this capacity, he works closely with the Pro-Life Secretariat to develop messages, promote issues and legislation, develop new programs and materials and implement communications strategies designed to educate the public and promote pro-life issues in the public square. These issues include abortion, assisted suicide and euthanasia, and bioethical issues, especially cloning and stem cell research. In 1996, Mr. Tarne helped found the Physicians Ad Hoc Coalition for Truth (PHACT), an organization of doctors and other medical professionals formed to bring the medical facts to bear on the partial-birth abortion debate. Mr. Tarne also served as Communications Director for Do No Harm: The Coalition of Americans for Research Ethics, a coalition of scientists, researchers, bioethicists, medical, academic and other professionals, patient advocates, and concerned individuals, established in 1999, to promote the ethical pursuit of stem cell research and regenerative medicine in general, and to provide accurate information on such research. Mr. Tarne graduated from Georgetown University in 1977 with a B.A. in Theology. He received his M.A. in History of Religions from The George Washington University in 1979. He was offered scholarships to Harvard, the University of Chicago and the University of Pennsylvania to pursue a Ph.D. in South Asian Studies. He attended the University of Chicago and later the University of Pennsylvania, where he completed his Ph.D. studies, except for dissertation.

Research Authored

featured-image
Stem Cells & Therapies

Fox Foundation Funding Patterns Favor Ethical Approaches

Beginning in the 1990’s, and throughout the first years of the 21st century, perhaps no other political or social cause célèbre attracted as many celebrities as human embryonic stem cell research (hESCR). Christopher Reeve, Kevin Kline, Michael J. Fox and Mary Tyler

featured-image
Stem Cells & Therapies

California Stem Cell Clinical Trials Show Ethical Alternatives Are Most Promising

featured-image
Stem Cells & Therapies

Time to End Embryo-Destroying Stem Cell Research

Will induced pluripotent stem cells (iPSCs) finally replace human embryonic stem cells (hESCs) in the field of regenerative medical research? Results of a recent study published in Nature Biotechnology argue that they should. First, some background. In 2007, Japanese scientist Shinya Yamanaka

featured-image
Stem Cells & Therapies

Stem Cell Awareness Day: Major Research Center’s Quest for Cures Uses Ethical Sources Only

featured-image
Stem Cells & Therapies

Clarifying a White House Letter on Stem Cell Research

The White House recently launched a site on Tumblr to feature letters sent to the president by the American people. The handful of letters posted so far cover a variety of subjects, including the usual suspects such as jobs, wages, healthcare and

featured-image
Stem Cells & Therapies

Stem Cell Research: Predictions, Predilections and Progress

featured-image
Stem Cells & Therapies

Ethical Adult Stem Cell Treatments Result in “Profound Improvement” for MS Patients

British media are reporting a significant development in the use of ethical, non-embryonic stem cells to treat patients with multiple sclerosis (MS) and, perhaps, other auto-immune diseases. Auto-immune diseases are caused by an abnormal immune response which causes the immune system to

featured-image
Stem Cells & Therapies

The Continuing Promise of Non-Embryonic Stem Cells

featured-image
Stem Cells & Therapies

Scientific Advances in Stem Cell Research Continue to Make Use of Embryos Outdated and Unnecessary

Diabetes has long been one of the main diseases for which human embryonic stem cell (embryo-destroying) research, or hESCR, was claimed to hold the greatest promise of curing. But for well over a decade now, ethically contentious human embryonic stem cell research

featured-image
Fetal Tissue, Stem Cells & Bioethics

Ethical Stem Cells Provide Model for Progress in Down Syndrome Research